Back
Pyxis Oncology Stock Price Chart
Sponsored
PYXS
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
13
PYXS
Pyxis Oncology
Last Price:
$1.43
Seasonality Move:
99.3%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PYXS is experiencing slight buying pressure.
Pyxis Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Sell |
20-day SMA: | 1.62 | Sell |
50-day SMA: | 2.47 | Sell |
200-day SMA: | 3.47 | Sell |
8-day EMA: | 1.62 | Sell |
20-day EMA: | 1.72 | Sell |
50-day EMA: | 2.22 | Sell |
200-day EMA: | 3.08 | Sell |
Pyxis Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | 318791 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.56 - 1.7) | Sell |
Bollinger Bands (100): | (2.04 - 4) | Sell |
Pyxis Oncology Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pyxis Oncology Stock
Is Pyxis Oncology Stock a Buy?
-
Pyxis Oncology share price is 1.53 while PYXS 8-day simple moving average is 1.64, which is a Sell signal.
-
The stock price of PYXS is 1.53 while Pyxis Oncology 20-day SMA is 1.62, which makes it a Sell.
-
Pyxis Oncology 50-day simple moving average is 2.47 while PYXS share price is 1.53, making it a Sell technically.
-
PYXS stock price is 1.53 and Pyxis Oncology 200-day simple moving average is 3.47, creating a Sell signal.
PYXS Technical Analysis vs Fundamental Analysis
Sell
13
Pyxis Oncology (PYXS)
is a Sell
Is Pyxis Oncology a Buy or a Sell?
-
Pyxis Oncology stock is rated a SellThe current Pyxis Oncology [PYXS] share price is $1.53. The Score for PYXS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Pyxis Oncology Stock Info
Market Cap:
91M
Price in USD:
1.53
Share Volume:
743.8K
Pyxis Oncology 52-Week Range
52-Week High:
6.85
52-Week Low:
1.48
Sell
13
Pyxis Oncology (PYXS)
is a Sell
Pyxis Oncology Share Price Forecast
-
What is the Pyxis Oncology stock price today?The Pyxis Oncology stock price is 1.53 USD today.
-
Will PYXS stock go up or go down?Pyxis Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Pyxis Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pyxis Oncology is overvalued.
Is Pyxis Oncology Stock a Buy?
-
Pyxis Oncology share price is 1.53 while PYXS 8-day exponential moving average is 1.62, which is a Sell signal.
-
The stock price of PYXS is 1.53 while Pyxis Oncology 20-day EMA is 1.72, which makes it a Sell.
-
Pyxis Oncology 50-day exponential moving average is 2.22 while PYXS share price is 1.53, making it a Sell technically.
-
PYXS stock price is 1.53 and Pyxis Oncology 200-day simple moving average is 3.08, creating a Sell signal.
Fundamental Analysis of Pyxis Oncology
Is Pyxis Oncology a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.07 per share.
Technical Analysis of Pyxis Oncology
Should I short Pyxis Oncology stock?
-
PYXS Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Pyxis Oncology is a Sell
-
Pyxis Oncology Relative Strength Index (RSI) is 34.97, which suggest Pyxis Oncology is oversold
-
The Bollinger Bands (25) for Pyxis Oncology is (1.56 - 1.7), which suggest Pyxis Oncology is a Sell
-
The Bollinger Bands (100) for Pyxis Oncology is (2.04 - 4), which suggest Pyxis Oncology is a Sell
* Pyxis Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.